Cited 47 times in
Phase I and Pharmacokinetic study of the oral fluoropyrimidine S-1 on a Once-Daily-for-28-day schedule in patients with advanced malignancies
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.